Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Summer Zhuang
Institution:
Lyell Immunopharma (United States)
Observed institutions:
Fred Hutch Cancer Center,
Lyell Immunopharma (United States)
ORCID:
0000-0002-1436-373X
Observed ORCID:
0000-0002-1436-373X
OpenAlex ID:
A5078578318
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy
2020
·
Shannon K. Oda
, Kristin G. Anderson
, et al.
·
The Journal of Experimental Medicine
·
64
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies
2021
·
Shamin Li
, Yannick Simoni
, et al.
·
Proceedings of the National Academy of Sciences
·
61
Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinct
2022
·
Shamin Li
, Summer Zhuang
, et al.
·
OncoImmunology
·
50
PDF
High-dimensional profiling of tumor-infiltrating CD4+T cells in Human cancer: Are they all tumor-specific?
2020
·
Shamin Li
, Yannick Simoni
, et al.
·
The Journal of Immunology
·
3
175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer
2020
·
Shannon Oda
, Kristin Anderson
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Unsuccessful checkpoint blockade and vaccination therapy despite expansion of tumor neoantigen-specific CD8 T cells in the Lewis Lung Carcinoma (LLC) model
2020
·
Shamin Li
, Yannick Simoni
, et al.
·
The Journal of Immunology
·
1
Abstract 4067: Development of tumor-restricted IL-12 with antigen-dependent expression and localized IL-12 activity
2024
·
Szu-Han Huang
, Thaddeus M. Davenport
, et al.
·
Cancer Research
1047 Protein design and inducible expression allow context-dependent, localized IL-12 activity to enhance solid tumor T cell therapies
2023
·
Thaddeus M Davenport
, Szu-han Huang
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract 3910: Cellular profiling of leukapheresis and infusion products of patients enrolled in CD19 CAR T cell therapy identifies biomarkers associated with clinical outcomes
2022
·
Tony Chour
, Alexandre Hirayama
, et al.
·
Cancer Research
Profiling antigen specificity concurrently with protein and mRNA quantification using high throughput single-cell multiomics reveal surprising similarities between bystander and tumor specific CD8+ tumor-infiltrating lymphocytes (TILs) in renal cell carcinoma (RCC).
2020
·
Aaron Tyznik
, Yannick Simoni
, et al.
·
Journal of Clinical Oncology
Antigen-specificity/protein/mRNA single-cell sequencing profiling of bystander CD8+tumor-infiltrating lymphocytes (TILs) in renal cell carcinoma (RCC) reveals their transcriptomic similarities with tumor-specific T cells
2020
·
Shamin Li
, Yannick Simoni
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
11
Citation count:
180
H-index:
3
I10-index:
3
Year
Topic
Type
